- Home
- QNCX vs EPM Comparison
QNCX vs EPM Comparison
Compare QNCX & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QNCX | EPM |
|---|---|---|
| Founded | 2012 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 158.2M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | QNCX | EPM |
|---|---|---|
| Price | $0.10 | $4.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $10.00 | $4.93 |
| AVG Volume (30 Days) | ★ 33.4M | 436.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.08% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $43,229,621.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $95.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.09 | $3.19 |
| 52 Week High | $4.55 | $5.70 |
Technical Indicators
Market Signals| Indicator | QNCX | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 27.86 | 64.56 |
| Support Level | $0.09 | $4.38 |
| Resistance Level | $0.98 | $5.13 |
| Average True Range (ATR) | 0.01 | 0.16 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 18.57 | 71.30 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.